Tirzepatide — lab test, July 2026
COA -2026-EDOL2U matches ILS Laboratories's public record. So this test doesn't rest on our review alone — the lab confirms it too.
BNPCYJN2Test results
Not on file for this certificate: sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 40 mg · Lab measured 42.14 mg
105% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 10.5 mg using the measured mass, against 10 mg on the label — 5% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | -2026-EDOL2U |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | ILS Laboratories's portal shows validity only |
| Submitted via | Peptigrity staff |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide, performed by ILS Laboratories on July 10, 2026. Reported purity: 99.95%. Net content: 42.14 mg against 40 mg labeled (105% of label). Endotoxins: 0.077 EU/mL. Batch CR-2XAG40-2607-Green. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion